Pharmaceuticals: Germany Industry Guide

Pharmaceuticals: Germany Industry Guide is an essential resource for top-level data and analysis covering the Germany Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals.

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Highlights

* The German biotechnology market grew by 7.8% in 2007 to reach a value of $5,026 million.

* The German generics market generated total revenues of $9.9 billion in 2007, representing a compound annual growth rate (CAGR) of 17% for the period spanning 2003-2007.

* The German OTC pharmaceuticals market generated total revenues of $6.8 billion in 2008, representing a compound annual growth rate (CAGR) of 1.2% for the period spanning 2004-2008.

* The German pharmaceutical market generated total revenues of $36.2 billion in 2008, representing a compound annual growth rate (CAGR) of 2.9% for the period spanning 2004-2008.

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

CHAPTER 1 BIOTECHNOLOGY IN GERMANY 10
1.1 Market Overview 10
1.2 Market Value 12
1.3 Market Segmentation I 13
1.4 Market Segmentation II 14
1.5 Five Forces Analysis 15
1.6 Market Forecasts 21
CHAPTER 2 GENERICS IN GERMANY 22
2.1 Market Overview 22
2.2 Market Value 24
2.3 Market Segmentation I 25
2.4 Market Segmentation II 26
2.5 Five Forces Analysis 27
2.6 Market Forecasts 34
CHAPTER 3 OTC PHARMACEUTICALS IN GERMANY 35
3.1 Market Overview 35
3.2 Market Value 37
3.3 Market Segmentation I 38
3.4 Market Segmentation II 39
3.5 Market Share 40
3.6 Five Forces Analysis 41
3.7 Distribution 47
3.8 Market Forecasts 48
CHAPTER 4 PHARMACEUTICALS IN GERMANY 49
4.1 Market Overview 49
4.2 Market Value 51
4.3 Market Segmentation I 52
4.4 Market Segmentation II 53
4.5 Market Share 54
4.6 Five Forces Analysis 55
4.7 Market Forecasts 62
CHAPTER 5 DEMOGRAPHICS 63
CHAPTER 6 APPENDIX 65
6.1 Data Research Methodology 65


LIST OF TABLES
Table 1: Germany Biotechnology Market Value: $ million, 2003-2007 12
Table 2: Germany Biotechnology Market Segmentation I: % Share, by Value, 2007 13
Table 3: Germany Biotechnology Market Segmentation II: % Share, by Value, 2007 14
Table 4: Germany Biotechnology Market Value Forecast: $ million, 2007-2012 21
Table 5: Germany Generics Market Value: $ billion, 2003-2007 24
Table 6: Germany Generics Market Segmentation I: % Share, by Value, 2007 25
Table 7: Germany Generics Market Segmentation II: % Share, by Value, 2007 26
Table 8: Germany Generics Market Value Forecast: $ billion, 2007-2012 34
Table 9: Germany OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e) 37
Table 10: Germany OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 38
Table 11: Germany OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 39
Table 12: Germany OTC Pharmaceuticals Market Share: % Share, by Value, 2007 40
Table 13: Germany OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 47
Table 14: Germany OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 48
Table 15: Germany Pharmaceuticals Market Value: $ million, 2003-2007 51
Table 16: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 52
Table 17: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 53
Table 18: Germany Pharmaceuticals Market Share: % Share, by Value, 2007 54
Table 19: Germany Pharmaceuticals Market Value Forecast: $ million, 2007-2012 62
Table 20: Germany Size of Population (million) , 2003-2007 63
Table 21: Germany GDP (Constant 2000 Prices, $ billion), 2003-2007 63
Table 22: Germany Inflation, 2003-2007 63
Table 23: Germany Exchange Rate, 2003 64


LIST OF FIGURES
Figure 1: Germany Biotechnology Market Value: $ million, 2003-2007 12
Figure 2: Germany Biotechnology Market Segmentation I: % Share, by Value, 2007 13
Figure 3: Germany Biotechnology Market Segmentation II: % Share, by Value, 2007 14
Figure 4: Forces Driving Competition in the Biotechnology Market in Germany, 2007 15
Figure 5: Drivers of Buyer Power in the Biotechnology Market in Germany, 2007 16
Figure 6: Drivers of Supplier Power in the Biotechnology Market in Germany, 2007 17
Figure 7: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in Germany, 2007 18
Figure 8: Factors Influencing the Threat of Substitutes in the Biotechnology Market in Germany, 2007 19
Figure 9: Drivers of Degree of Rivalry in the Biotechnology Market in Germany, 2007 20
Figure 10: Germany Biotechnology Market Value Forecast: $ million, 2007-2012 21
Figure 11: Germany Generics Market Value: $ billion, 2003-2007 24
Figure 12: Germany Generics Market Segmentation I: % Share, by Value, 2007 25
Figure 13: Germany Generics Market Segmentation II: % Share, by Value, 2007 26
Figure 14: Forces Driving Competition in the the Generics Market in Germany, 2007 27
Figure 15: Drivers of Buyer Power in the the Generics Market in Germany, 2007 29
Figure 16: Drivers of Supplier Power in the the Generics Market in Germany, 2007 30
Figure 17: Factors Influencing the Likelihood of New Entrants in the the Generics Market in Germany, 2007 31
Figure 18: Factors Influencing the Threat of Substitutes in the the Generics Market in Germany, 2007 32
Figure 19: Drivers of Degree of Rivalry in the Generics Market in Germany, 2007 33
Figure 20: Germany Generics Market Value Forecast: $ billion, 2007-2012 34
Figure 21: Germany OTC Pharmaceuticals Market Value: $ billion, 2004- 2008(e) 37
Figure 22: Germany OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 38
Figure 23: Germany OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 39
Figure 24: Germany OTC Pharmaceuticals Market Share: % Share, by Value, 2007 40
Figure 25: Forces Driving Competition in the OTC Pharmaceuticals Market in Germany 41
Figure 26: Drivers of Buyer Power in the OTC Pharmaceuticals Market in Germany 42
Figure 27: Drivers of Supplier Power in the OTC Pharmaceuticals Market in Germany 43
Figure 28: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in Germany 44
Figure 29: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in Germany 45
Figure 30: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in Germany 46
Figure 31: Germany OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 47
Figure 32: Germany OTC Pharmaceuticals Market Value Forecast: $ billion, 2008-2013 48
Figure 33: Germany Pharmaceuticals Market Value: $ million, 2003-2007 51
Figure 34: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 52
Figure 35: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 53
Figure 36: Germany Pharmaceuticals Market Share: % Share, by Value, 2007 54
Figure 37: Forces Driving Competition in the Pharmaceuticals Market in Germany, 2007 55
Figure 38: Drivers of Buyer Power in the Pharmaceuticals Market in Germany, 2007 56
Figure 39: Drivers of Supplier Power in the Pharmaceuticals Market in Germany, 2007 57
Figure 40: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Germany, 2007 59
Figure 41: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Germany, 2007 60
Figure 42: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Germany, 2007 61
Figure 43: Germany Pharmaceuticals Market Value Forecast: $ million, 2007-2012 62